Effect of chronic apocynin treatment on nitric oxide and reactive oxygen species production in borderline and spontaneous hypertension

Pharmacological Reports

Volumn 61, Issue 1, 2009, Pages 116-122

  Pechánová, Olga ^a,b   Jendeková, Lýdia ^a   Vranková, Stanislava ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Apocynin; Experimental hypertension; NAD(P)H oxidase; NF kappa B; NO synthase; Reactive oxygen species

Indexed keywords

APOCYNIN; CYCLIC GMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN P22PHOX; PROTEIN P67PHOX; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA; BLOOD PRESSURE REGULATION; BORDERLINE HYPERTENSION; BORDERLINE HYPERTENSIVE RAT; CHRONIC DRUG ADMINISTRATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE; MALE; NONHUMAN; PLETHYSMOGRAPHY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TISSUE LEVEL; TREATMENT DURATION;

EID: 66949180360     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70013-1     Document Type: Conference Paper

References (32)

1. Auch-Schwelk W, Katusic ZS, Vanhoutte PM: Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension, 1989, 13, 859-864.
2. Barbieri SS, Cavalca V, Eligini S, Brambilla M, Caiani A, Tremoli E, Colli S: Apocynin prevents cyclooxygenase 2 espression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free Radic Biol Med, 2004, 37, 156-165.
3. Bauersachs J, Widder JD: Endothelial dysfunction in heart failure. Pharmacol Rep, 2008, 60, 119-126.
4. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA, 1990, 87, 1620-1624.
5. Beswick RA, Dorrance AM, Leite R, Webb RC: NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension, 2001, 38, 1107-1111.
6. Bredt DS, Snyder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA, 1990, 87, 682-685.
7. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS: Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension, 2002, 39, 269-274.
8. Chen X, Touyz RM, Park JB, Schiffrin EL: Antioxidant effects of vitamins C and E are associated with altered activation of vascular NAD(P)H oxidase and superoxide dismutase in stroke-prone SHR. Hypertension, 2001, 38, 606-611.
9. Dworakowski R, Alom-Ruiz SP, Shah AM: NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. Pharmacol Rep, 2008, 60, 21-28.
10. Haddad JJ: Oxygen-sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiology. Respir Res, 2002, 3, 26.
11. Hayashi T, Juliet PA, Kano-Hayashi H, Tsunekawa T, Dingqunfang D, Sumi D, Matsui-Hirai H et al.: NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction. Diabetes Obes Metab, 2005, 7, 334-343.
12. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA: Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension, 1999, 33, 1353-1358.
13. Lassegue B, Clempus RE: Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol, 2003, 285, R277-R297.
14. Lodi F, Cogolludo A, Duarte J, Moreno L, Coviello A, De Bruno MP, Vera R et al.: Increased NADPH oxidase activity mediates spontaneous aortic tone in genetically hypertensive rats. Eur J Pharmacol, 2006, 544, 97-103.
15. Lounsbury KM, Hu Q, Ziegelstein RC: Calcium signaling and oxidant stress in the vasculature. Free Radic Biol Med, 2000, 28, 1362-1369.
16. Małek R, Borowicz KK, Jargie33o M, Czuczwar SJ: Role of nuclear factor kappaB in the central nervous system. Pharmacol Rep, 2007, 59, 25-33.
17. Mohazzab KM, Kaminski PM, Wolin MS: NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol, 1994, 266, H2568-H 2572.
18. Morawietz H, Weber M, Rueckschloss U, Lauer N, Hacker A, Kojda G: Upregulation of vascular NAD(P)H oxidase subunit gp91phox and impairment of the nitric oxide signal transduction pathway in hypertension. Biochem Biophys Res Commun, 2001, 285, 1130-1135.
19. Pagano P, Ito Y, Tornheim K, Gallop P, Tauber A, Cohen R: An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol, 1995, 68, H2274-H2280.
20. Park YM, Park MY, Suh YL, Park JB: NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats. Biochem Biophys Res Commun, 2004, 313, 812-817.
21. Pechanova O: Contribution of captopril thiol group to the prevention of spontaneous hypertension. Physiol Res, 2007, 56, Suppl 2, S41-S48.
22. Pechanova O, Bernatova I: Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues. Physiol Res, 1996, 45, 305-309.
23. Pechanova O, Matuskova J, Capikova D, Jendekova L, Paulis L, Simko F: Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats. Kidney Int, 2006, 70, 170-176.
24. Pechanova O, Zicha J, Kojsova S, Dobesova Z, Jendekova L, Kunes J: Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clin Sci (Lond), 2006, 110, 235-242.
25. Pechanova O, Zicha J, Paulis L, Zenebe W, Dobesova Z, Kojsova S, Jendekova L et al.: The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol, 2007, 561, 129-136.
26. Polizio AH, Gironacci MM, Tomaro ML, Peña C: Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production. Pharmacol Res, 2007, 56, 86-90.
27. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling K K, Harrison DG: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NAD(P)H oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest, 1996, 97, 1916-1923.
28. Somers MJ, Mavromatis K, Galis ZS, Harrison DG: Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetatesalt. Circulation, 2000, 101, 1722-1728.
29. Vaziri ND, Ni ZM, Oveisi F: Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension, 1998, 31, 1248-1254.
30. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL: Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens, 2004, 22, 535-542.
31. Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Diez J: Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction? Nephrol Dial Transplant, 2001, 16, 2-5.
32. Zalba G, Beaumont FJ, San José G, Fortuño A, Fortuño MA, Etayo JC, Diez J: Vascular NADH/NAD(P)H oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension, 2000, 35, 1055-1061.